🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1R allosteric modulators — 12 month update Page 3

GLP-1R allosteric modulators — 12 month update

InsuranceTom Sun, Mar 15, 2026 at 3:41 PM 18 replies 814 viewsPage 3 of 4
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Mar 17, 2026 at 2:44 AM#11
Dr.CardioMD said:
PK/PD modeling for the pharmacology: understanding the pharmacokinetics helps optimize dosing.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Correct me if the detail matters more than I have assumed.

Last edited: Mar 17, 2026 at 4:44 AM
25 0Dr.NateNeph, PharmD_Rodriguez, julia.endo and 22 others
Reply Quote Save Share Report
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Mar 17, 2026 at 8:22 PM#12
EndoResFellow said:
The mechanism is more central than most summaries suggest.

Genuinely useful, thank you. I had the facts and not the framework. Taking it to my next appointment.

Last edited: Mar 17, 2026 at 10:22 PM
24 24NeuroNate, JessicaH_TX, KevinCompounds and 21 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Mar 18, 2026 at 1:59 PM#13
Dr.CardioMD said:
PK/PD modeling for the pharmacology: understanding the pharmacokinetics helps optimize dosing.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

Last edited: Mar 18, 2026 at 3:59 PM
23 23HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Mar 19, 2026 at 7:36 AM#14

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

22 22hans_munich, jason_sac26, chris_chi24 and 19 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 20, 2026 at 1:12 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

21 21PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 18 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register